Conference
Phase I pharmacokinetic study of single agent trametinib in advanced cancer patients with hepatic dysfunction: An NCI Organ Dysfunction Working Group (ODWG) study.
Authors
Spreafico A; Chen E; Sahebjam S; Renouf DJ; Kelly K; Lockhart AC; Vaishampayan UN; Hotte SJ; Razak AR; Wang L
Volume
34
Pagination
pp. 2578-2578
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2016
DOI
10.1200/jco.2016.34.15_suppl.2578
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X